Legislative and legal realities at the state and federal levels are difficult to navigate even for seasoned practitioners, and are beyond the knowledge of most families.

"Any decent realtor, walking you through a real shithole, chirps on about good bones: This place could be beautiful, right? You could make this place beautiful."

Chelsea Monroe, MSN, APN, PMHNP-BC, discusses the current renaissance in treating schizophrenia.

Celebrate our 40th anniversary with Gustavo Alva, MD, FAPA, our Mood Disorders Section Editor.

Check out new data from the long-term, open-label KINECT 4 study on Ingrezza capsules for the treatment of tardive dyskinesia.

Learn more about a condition that is often underestimated and mistaken for typical premenstrual symptoms or mood swings: premenstrual dysphoric disorder.

Residents and early career psychiatrists are concerned about the state of psychiatry.

Let's process our trauma, grief, and healing from COVID-19.

Based on a new study, ketamine may be preferred among outpatients and for those with “moderately severe or severe” depression, whereas ECT may be preferred among inpatients and those with “very severe” depression.

Alzamend announced a late 2025 initiation for the phase 2 clinical study of AL001, a novel lithium-delivery system for the treatment of patients with major depressive disorder.

Through cinematherapy, Ted Perkins created a program centered on addiction in film that is now used in recovery centers and clinics across the US and Canada.

"I guessed heart failure. The answer was pneumonia."

Can cooperation in space have any implications for better cultural cooperation on earth?

Subscribe to our brand new LinkedIn newsletter!

March 17 through March 23 is National Drug and Alcohol Facts Week 2025.

As we celebrate the anniversary of COVID-19, let’s examine what meaning the pandemic brought to our lives.

In this sponsored video series, review common challenges associated with the treatment of schizophrenia, such as treatment nonadherence and relapse.

Although diagnostic criteria for a depressive episode are the same for unipolar major depression and bipolar depression, these episodes differ in their natural history.

"I stood by her side, stunned when her breathing stopped..."

Are these the times that try psychiatrists’ souls?

A new transcranial direct current stimulation device received approval from the FDA for an investigational device exemption, prompting a phase 3 trial.

Digital communication is a powerful tool, but without clear boundaries, it can blur the line between education and clinical care, leading to ethical and professional challenges.

A one-size-fits-all approach does not work—each mother’s experience with postpartum depression is unique.

These words related to psychiatry are officially being banned.

Rejoyn, a new app being prescribed as a depression treatment, is an emotional face memory task designed to correct abnormal neural circuits.